There is no shortage of medicines needed by epilepsy patients in Russia. In this respect City News Agency “Moscow” said epileptologist Yuri Solomatin, neurologist of the Federal Center for Brain and Neurotechnology of the Russian Federal Agency for Medicine and Biology (FMBA).
“Since new domestic medicines have been and are being produced, the sanctions do not affect the treatment of the disease. Most international analogues are produced by our manufacturers. There are enough domestic drug analogues in Russia,” said the doctor.
Solomatin added that there are one to three active epilepsy patients for every thousand people in Moscow. According to the doctor, 75% of cases occur in childhood or adolescence, but it can also occur in adulthood. The likelihood of this increases due to traumatic brain injury and some diseases affecting the brain (cancer, dementia and other types of neurodegeneration, benign tumors, disorders of blood flow to the brain).
used to be a doctor in the name The main mistake in the treatment of epilepsy in the elderly.